The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancers

Colorectal Disease

Volumn 15, Issue 5, 2013, Pages 536-543

  Lim, M ^a   Hussain, Z ^a   Howe, A ^a   Storey, R ^a   Petty, D ^a   Haselden, J ^a   Sebag Montefiore, D ^b   Alexander, D ^a  

^a YORK HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Colon cancer; Foxtrot; Preoperative CT staging; Survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLON, ASCENDING; COLON, TRANSVERSE; COLONIC NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877007144     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12061     Document Type: Article

References (19)

1. The National Bowel Cancer Audit Project (NBOCAP). http://www.ic.nhs.uk/catalogue/PUB09352. (accessed December 2012).
2. Faivre J, Lemmens VE, Quipourt V, Bouvier AM. Management and survival of colorectal cancer in the elderly in population-based studies. Eur J Cancer 2007; 43: 2279-84.
3. West N, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncological superior specimen when compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010; 28: 272-8.
4. Smith NJ, Bees N, Barbachano Y, Norman AR, Swift RI, Brown G. Pre-operative computed tomography staging of non-metastatic colon cancer predicts outcome: implications for clinical trials. Br J Cancer 2007; 96: 1030-6.
5. Dighe S, Swift I, Magill L etal. Accuracy of radiological staging in identifying high risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience. Colorectal Dis 2012; 14: 438-444.
6. Dighe S, Blake H, Koh M-D etal. Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. Br J Surg 2010; 97: 1407-15.
7. UKCCCR guidelines for histopathology reporting. The Royal College of Pathologists Working Group on Cancer Services: UK Guidelines. London, Royal College of Pathologists, 1998.
8. Quasar Collaborative Group; Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370: 2020-9.
9. Fisher A, Rahmani S, Turvill S. The effect of preoperative therapy on the body composition and cardiopulmonary status of patients with colorectal cancer. (Abstract) BASO meeting, London, November 2010.
10. Lyall A, McAdam TK, Townend J, Loudon MA. Factors affecting anastomotic complications following anterior resection in rectal cancer. Colorectal Dis 2007; 9: 801-7.
11. Navarro GV, Mompeán JA, Agüera QH etal. Influence of the neo-adjuvant radiochemotherapy as a factor in the surgical treatment of rectal cancer by expert surgeon. A comparative study. Int J Colorectal Dis 2007; 22: 1233-8.
12. Martel G, Al-Suhaibani Y, Moloo H etal. Neoadjuvant therapy and anastomotic leak after tumor-specific mesorectal excision for rectal cancer. Dis Colon Rectum 2008; 51: 1195-201.
13. The Foxtrot Study. University of Birmingham. http://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/coloproctology/foxtrot/index.aspx. (accessed December 2010).
14. Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant Chemotherapy Use for Medicare Beneficiaries With Stage II Colon Cancer. J Clin Oncol 2002; 20: 3999-4005.
15. Gill S, Loprinzi C, Sargent D etal. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004; 22: 1797-1806.
16. Benson AB, Schrag D, Somerfield M etal. American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer. J Clin Oncol 2004; 22: 3408-19.
17. Squillaci E, Manenti G, Mancino S etal. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT-initial clinical experience. Abdom Imaging 2008; 33: 676-88.
18. Khan S, Tan YM, John A etal. An audit of fusion CT-PET in the management of colorectal liver metastases. Eur J Surg Oncol 2006; 32: 564-7.
19. Chowdhury FU, Shah N, Scarsbrook AF, Bradley KM. (18F) FDG PET/CT imaging of colorectal cancer. Postgrad Med J 2010; 86: 174-82.